These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3953383)

  • 1. Relationship between ease of inducibility of arrhythmia with electrophysiologic testing and response to antiarrhythmic therapy.
    Amann FW; Blatt CM; Podrid PJ; Lown B
    Am Heart J; 1986 Apr; 111(4):625-31. PubMed ID: 3953383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased incidence of antiarrhythmic drug efficacy at electrophysiologic study associated with the use of a third extrastimulus.
    Swerdlow CD; Blum J; Winkle RA; Griffin JC; Ross DL; Mason JW
    Am Heart J; 1982 Nov; 104(5 Pt 1):1004-11. PubMed ID: 7136990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.
    Belhassen B; Shapira I; Shoshani D; Paredes A; Miller H; Laniado S
    Circulation; 1987 Apr; 75(4):809-16. PubMed ID: 3829343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous arrhythmia detected on ambulatory electrocardiographic recording lacks precision in predicting inducibility of ventricular tachycardia during electrophysiologic study.
    Pratt CM; Thornton BC; Magro SA; Wyndham CR
    J Am Coll Cardiol; 1987 Jul; 10(1):97-104. PubMed ID: 3598001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
    Poser RF; Podrid PJ; Lombardi F; Lown B
    Am Heart J; 1985 Jul; 110(1 Pt 1):9-16. PubMed ID: 4013993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.
    Steinbeck G; Andresen D; Bach P; Haberl R; Oeff M; Hoffmann E; von Leitner ER
    N Engl J Med; 1992 Oct; 327(14):987-92. PubMed ID: 1355595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electrophysiologic testing: its role in the selection of antiarrhythmic drug regimens for supraventricular and ventricular arrhythmias.
    Cameron J; Isner JM; Salem DM; Estes NA
    Pharmacotherapy; 1985; 5(2):95-107. PubMed ID: 3889871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias.
    Kelly PA; Cannom DS; Garan H; Finkelstein D; McComb JM; Mirabal GS; Ilvento JP; Ruskin JN
    Am J Cardiol; 1988 Jul; 62(1):83-7. PubMed ID: 3381756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure.
    Stevenson WG; Stevenson LW; Weiss J; Tillisch JH
    Am Heart J; 1988 Dec; 116(6 Pt 1):1447-54. PubMed ID: 3195428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot.
    Deal BJ; Scagliotti D; Miller SM; Gallastegui JL; Hariman RJ; Levitsky S
    Am J Cardiol; 1987 Jun; 59(15):1380-5. PubMed ID: 3591695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of reproducibility of baseline arrhythmia induction on drug efficacy predictions and outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial.
    Mann DE; Hartz V; Hahn EA; Reiter MJ
    Am J Cardiol; 1997 Dec; 80(11):1448-52. PubMed ID: 9399720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the electrophysiologic study predict treatment outcome in patients with sustained ventricular tachyarrhythmias unrelated to coronary artery disease?
    Davis LM; Cooper MJ; Sadick N; Byth K; Uther JB; Richards DA; Ross DL
    Int J Cardiol; 1994 Jun; 45(1):53-68. PubMed ID: 7995663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
    Weintraub AR; Manolis AS; Estes NA
    Am J Cardiol; 1990 Oct; 66(12):947-53. PubMed ID: 2121017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uses and limitations of electrophysiology studies for the selection of antiarrhythmic therapy.
    Kowey PR; Friehling TD
    Pacing Clin Electrophysiol; 1986 Mar; 9(2):231-47. PubMed ID: 2419873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.